Evolus Inc (NASDAQ:EOLS)

14.01
Delayed Data
As of Oct 11
 -0.08 / -0.57%
Today’s Change
10.22
Today|||52-Week Range
30.25
+17.73%
Year-to-Date
No recent news for Evolus Inc.

Today’s Trading

Previous close14.09
Today’s open14.20
Day’s range13.95 - 14.55
Volume179,207
Average volume (3 months)517,643
Market cap$387.8M
Data as of 4:00pm ET, 10/11/2019

Growth & Valuation

Earnings growth (last year)-611.33%
Earnings growth (this year)-85.81%
Earnings growth (next 5 years)+47.05%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.57

Competitors

 Today’s
change
Today’s
% change
VRCAVerrica Pharmaceutic...+0.18+1.19%
AMAGAMAG Pharmaceuticals...-0.37-3.20%
TCRRTCR2 Therapeutics In...+0.80+5.40%
COLLCollegium Pharmaceut...-0.11-0.92%
Data as of 4:00pm ET, 10/11/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)-$1.16
Annual revenue (last year)$0.00
Annual profit (last year)-$46.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
David Moatazedi
Vice President-
Operations
Alejandro Sabad
Corporate headquarters
Newport Beach, California

Forecasts